# MT-45: A Synthetic Opioid With an Unusual Adverse Effect Profile

**Authors:** Markus D Moore, Adil K Shivji, Kerry Anne Rambaran, Steven W Fleming, Saeed K Alzghari

PMC · DOI: 10.7759/cureus.83771 · Cureus · 2025-05-09

## TL;DR

MT-45 is a synthetic opioid linked to rare and unusual side effects like hearing loss and hair changes.

## Contribution

The paper introduces MT-45 and highlights its unique adverse effect profile not commonly seen with other opioids.

## Key findings

- Three patients experienced ototoxicity after exposure to MT-45.
- Another three patients showed symptoms like visual impairment, dry eye, and hair changes.
- MT-45 should be considered in diagnosing patients with rare adverse effects.

## Abstract

The opioid crisis continues to be a problem in the United States. The rise of illicit synthetic opioids continues to be a threat to those that may unknowingly digest these substances. Herein, we present a synthetic opioid, MT-45, that has an unusual adverse effect profile. In one case series, three patients experienced ototoxicity. In a separate case series, three patients experienced a range of symptoms that included visual impairment, dry eye disorder, dermatitis, Mee's lines, alopecia, and hair depigmentation. Clinicians should consider MT-45 as part of their differential diagnosis if a patient is experiencing an uncommon adverse effect associated with MT-45.

## Linked entities

- **Chemicals:** MT-45 (PubChem CID 431865)

## Full-text entities

- **Diseases:** hair depigmentation (MESH:D006201), ototoxicity (MESH:D006311), dermatitis (MESH:D003872), visual impairment (MESH:D014786), alopecia (MESH:D000505), dry eye disorder (MESH:D015352)
- **Chemicals:** MT-45 (MESH:C012631)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12145568/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12145568/full.md

---
Source: https://tomesphere.com/paper/PMC12145568